Subscribe

Croda International Plc (CRDA.L)

GBp2,917.00 -9.00 (-0.31%)
GB LSE Basic Materials Chemicals - Specialty
Address Cowick Hall DN14 9AA
Goole, GB
CEO Stephen Edward Foots
Website croda.com
IPO 1988-07-01
ISIN GB00BJFFLV09

Explore sections of this company profile

Also trades on London Stock Exchange · 49GP.L (GBp) London Stock Exchange · 50GP.L (GBp) London Stock Exchange · CRDA.L (GBp) Other OTC · COIHF (USD) Other OTC · COIHY (USD)
Description

Croda International Plc, established in 1925 and headquartered in Goole, United Kingdom, is a global leader in the development, manufacture, and supply of high-performance specialty chemicals. The company serves a diverse international client base across Europe, the Middle East, Africa, North America, Asia, and Latin America. Its operations are organized into four primary business segments: Consumer Care, Life Sciences, Performance Technologies, and Industrial Chemicals. Croda's extensive product portfolio addresses a wide array of industrial and consumer needs. For the Consumer Care market, it delivers crucial ingredients for personal care products, spanning skin, hair, sun, and baby care, along with solutions for color cosmetics, oral hygiene, self-tanning, deodorants, men's grooming, and depilatories, as well as household and institutional cleaning formulations. In Life Sciences, the company provides innovative solutions for agriculture, including crop protection additives, seed enhancements, animal health chemicals, and bio-stimulants, alongside dietary supplements and active pharmaceutical ingredients. The Performance Technologies and Industrial Chemicals segments encompass a vast range of specialized materials. This includes additives for lubricants, coatings, polymers, batteries, and catalysts; materials for electronics, construction, and thermal management; adhesives; and chemicals for vehicle cleaning, automotive textiles, and plastic/rubber products. Furthermore, Croda supplies chemicals for packaging, printing, paper, paints, and water treatment, along with oleochemicals, emulsifiers, fuel additives, and specialty polymer additives for furniture and wood. The company also innovates in bio-based phase change materials, offering solutions for temperature control in buildings, clothing, healthcare, electronics, food refrigeration, energy storage, packaging, and automotive applications. This broad offering underscores Croda's commitment to delivering specialized chemical solutions across numerous critical industries.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
GBp2,917.00 -9.00 (-0.31%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
365.7K
Beta
0.92
Float Shares
126.47M
Free Float %
90.6%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-0.07% +0.66% +6.74% -1.71% +11.72% +12.84% -0.88% -50.21% -56.63% +0.97% +1,250.72%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Analyst Consensus (1 ratings, all time) Buy
Price Targets & DCF
Current price
2,917.00
DCF (Unlevered) 3,627.55 +24.4%
DCF (Levered) 1,520.94 -47.9%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 71% Bullish
Rating 2026-05 Change
Strong Buy 3 0
Buy 7 0
Hold 4 -1
Sell 0 -1
Strong Sell 0 0
Quality scores
Altman Z-Score
4.32
Safe zone
Piotroski F-Score
6 / 9
Average
MOAT Score
4 / 10
Developing
Composite Rating
B
Overall Score
3 / 5
Medium
DCF Score
4 / 5
High
ROE Score
3 / 5
Medium
ROA Score
4 / 5
High
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
  • ✗
    Revenue growth Chemicals - Specialty: +4.7%
    +4.4% Q4'25: +3.7% (vs Q4'23)
  • ✗
    EPS growth Chemicals - Specialty: +13.2%
    -61.4% Q4'25: -99.1% (vs Q4'23)
  • ✓
    FCF margin FCF growth · Chemicals - Specialty: +44.1%
    +11.8% Q4'25: +16.4% (vs Q4'23)
  • ✗
    EBIT margin Chemicals - Specialty: +8.8%
    +14.3% ★ Q4'25: +13.6% (vs Q4'23)
  • ✗
    ROIC Chemicals - Specialty: +5.6%
    +6.4% ★ Q4'25: +10.1% (vs Q4'23)
  • ✓
    Share dilution Chemicals - Specialty: +0.1%
    0.0% Q4'25: +2.2% (vs Q4'23)
  • ✓
    Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×
    1.83× Q4'25: 0.96× (vs Q4'23)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.90) × ERP
WACC = 86% × Ke + 14% × Kd (4.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Intrinsic value (base): 3,627.55 Current price: 2,917.00
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2001
actual 		Dec 2002
actual 		Dec 2003
actual 		Dec 2004
actual 		Dec 2005
actual 		Dec 2006
actual 		Dec 2007
actual 		Dec 2008
actual 		Dec 2009
actual 		Dec 2010
actual 		Dec 2011
actual 		Dec 2012
actual 		Dec 2013
actual 		Dec 2014
actual 		Dec 2015
actual 		Dec 2016
actual 		Dec 2017
actual 		Dec 2018
actual 		Dec 2019
actual 		Dec 2020
actual 		Dec 2021
actual 		Dec 2022
actual 		Dec 2023
actual 		Dec 2024
actual 		Dec 2025
actual 		Dec 2026
12 Rev. Ana.
11 EPS Ana. 		Dec 2027
13 Rev. Ana.
11 EPS Ana. 		Dec 2028
9 Rev. Ana.
6 EPS Ana. 		Dec 2029
4 Rev. Ana.
4 EPS Ana. 		Dec 2030
4 Rev. Ana.
2 EPS Ana.
Revenue
312.40M
est: 318.75M (-2.0%)
313.60M
est: 317.81M (-1.3%)
303.40M
est: 302.19M (+0.4%)
280.90M
est: 297.21M (-5.5%)
305.60M
est: 319.12M (-4.2%)
480.10M
est: 513.37M (-6.5%)
804.80M
est: 935.52M (-14.0%)
911.10M
est: 965.26M (-5.6%)
827.50M
est: 942.40M (-12.2%)
1.00B
est: 1.02B (-1.5%)
1.07B
est: 1.10B (-2.8%)
1.05B
est: 1.09B (-3.2%)
1.08B
est: 1.10B (-1.7%)
1.05B
est: 1.06B (-1.4%)
1.08B
est: 1.08B (+0.1%)
1.24B
est: 1.22B (+2.1%)
1.37B
est: 1.37B (+0.0%)
1.39B
est: 1.39B (-0.2%)
1.38B
est: 1.40B (-1.9%)
1.39B
est: 1.35B (+2.9%)
1.89B
est: 1.84B (+2.5%)
2.09B
est: 1.94B (+7.7%)
1.69B
est: 1.63B (+4.0%)
1.63B
est: 1.64B (-0.5%)
1.70B
est: 1.68B (+0.9%)
1.77B
1.72B – 1.84B
+5.0% YoY
1.85B
1.81B – 1.94B
+4.5% YoY
1.93B
1.92B – 1.94B
+4.5% YoY
2.04B
1.99B – 2.13B
+5.6% YoY
2.13B
2.08B – 2.23B
+4.7% YoY
EBITDA
55.80M
est: 45.61M (+22.4%)
56.50M
est: 44.37M (+27.3%)
62.10M
est: 18.70M (+232.1%)
61.20M
est: 54.39M (+12.5%)
68.40M
est: 62.28M (+9.8%)
50.80M
est: 100.38M (-49.4%)
117.80M
est: 55.95M (+110.6%)
135.90M
est: 115.25M (+17.9%)
129.00M
est: 104.85M (+23.0%)
237.20M
est: 81.61M (+190.6%)
284.60M
est: 237.89M (+19.6%)
287.20M
est: 262.26M (+9.5%)
291.10M
est: 250.59M (+16.2%)
273.10M
est: 266.57M (+2.5%)
294.80M
est: 265.60M (+11.0%)
333.00M
est: 320.02M (+4.1%)
376.30M
est: 359.60M (+4.6%)
385.50M
est: 373.94M (+3.1%)
386.30M
est: 370.51M (+4.3%)
369.60M
est: 335.52M (+10.2%)
549.40M
est: 358.25M (+53.4%)
924.80M
est: 371.35M (+149.0%)
388.50M
est: 461.70M (-15.9%)
374.50M
est: 465.51M (-19.6%)
380.70M
est: 477.17M (-20.2%)
500.97M
488.75M – 520.07M
+5.0% YoY
523.26M
511.55M – 550.72M
+4.5% YoY
546.74M
545.16M – 548.32M
+4.5% YoY
577.31M
563.82M – 603.56M
+5.6% YoY
604.65M
590.52M – 632.14M
+4.7% YoY
EBIT
40.60M
est: 38.61M (+5.2%)
12.70M
est: 39.38M (-67.8%)
47.50M
est: 11.01M (+331.5%)
46.70M
est: 45.14M (+3.4%)
54.40M
est: 48.32M (+12.6%)
30.50M
est: 84.46M (-63.9%)
90.90M
est: 44.47M (+104.4%)
121.80M
est: 79.86M (+52.5%)
106.50M
est: 110.13M (-3.3%)
203.00M
est: 111.85M (+81.5%)
252.40M
est: 214.55M (+17.6%)
256.10M
est: 235.07M (+8.9%)
258.50M
est: 257.46M (+0.4%)
238.00M
est: 255.04M (-6.7%)
258.50M
est: 249.64M (+3.5%)
286.30M
est: 294.80M (-2.9%)
326.60M
est: 322.96M (+1.1%)
329.90M
est: 332.07M (-0.7%)
319.90M
est: 331.40M (-3.5%)
290.50M
est: 305.36M (-4.9%)
437.20M
est: 326.04M (+34.1%)
805.70M
est: 337.96M (+138.4%)
262.20M
est: 345.61M (-24.1%)
238.70M
est: 379.85M (-37.2%)
243.70M
est: 357.18M (-31.8%)
375.00M
365.85M – 389.30M
+5.0% YoY
391.69M
382.92M – 412.24M
+4.5% YoY
409.26M
408.08M – 410.44M
+4.5% YoY
432.14M
422.04M – 451.79M
+5.6% YoY
452.61M
442.03M – 473.18M
+4.7% YoY
Net Income
21.30M
est: 26.75M (-20.4%)
-500.0K
est: 21.24M (-102.4%)
29.30M
est: -379.6K (+7,818.1%)
30.60M
est: 28.92M (+5.8%)
32.80M
est: 32.86M (-0.2%)
7.90M
est: 52.60M (-85.0%)
87.20M
est: 14.58M (+498.1%)
60.90M
est: 90.08M (-32.4%)
23.80M
est: 59.66M (-60.1%)
130.80M
est: 25.52M (+412.5%)
167.50M
est: 141.31M (+18.5%)
161.90M
est: 165.65M (-2.3%)
177.50M
est: 152.52M (+16.4%)
165.30M
est: 171.93M (-3.9%)
180.70M
est: 170.24M (+6.1%)
196.70M
est: 203.47M (-3.3%)
237.00M
est: 222.43M (+6.5%)
238.50M
est: 241.42M (-1.2%)
223.90M
est: 240.39M (-6.9%)
201.60M
est: 213.72M (-5.7%)
320.80M
est: 228.20M (+40.6%)
649.30M
est: 193.90M (+234.9%)
171.00M
est: 162.70M (+5.1%)
158.50M
est: 192.98M (-17.9%)
62.00M
est: 201.74M (-69.3%)
227.25M
211.55M – 242.95M
+12.6% YoY
254.63M
235.69M – 273.56M
+12.0% YoY
253.00M
252.02M – 292.43M
-0.6% YoY
303.97M
294.73M – 321.93M
+20.1% YoY
318.38M
308.71M – 337.20M
+4.7% YoY
SGA
—
est: 87.06M (-100.0%)
—
est: 86.81M (-100.0%)
—
est: 82.54M (-100.0%)
38.00M
est: 81.18M (-53.2%)
15.10M
est: 40.80M (-63.0%)
25.10M
est: 64.51M (-61.1%)
45.30M
est: 125.74M (-64.0%)
45.80M
est: 107.20M (-57.3%)
40.30M
est: 97.61M (-58.7%)
42.30M
est: 119.79M (-64.7%)
38.40M
est: 128.45M (-70.1%)
101.90M
est: 101.46M (+0.4%)
99.80M
est: 299.31M (-66.7%)
101.20M
est: 289.92M (-65.1%)
115.80M
est: 295.20M (-60.8%)
159.50M
est: 332.79M (-52.1%)
191.40M
est: 375.05M (-49.0%)
191.40M
est: 379.61M (-49.6%)
311.30M
est: 383.65M (-18.9%)
342.10M
est: 368.97M (-7.3%)
500.70M
est: 503.65M (-0.6%)
540.90M
est: 530.09M (+2.0%)
482.50M
est: 431.84M (+11.7%)
506.40M
est: 433.61M (+16.8%)
349.10M
est: 446.31M (-21.8%)
468.57M
457.14M – 486.43M
+5.0% YoY
489.42M
478.46M – 515.11M
+4.5% YoY
511.38M
509.90M – 512.86M
+4.5% YoY
539.97M
527.35M – 564.52M
+5.6% YoY
565.54M
552.32M – 591.25M
+4.7% YoY
EPS
0.17
est: 0.18 (-3.2%)
0.00
est: 0.19 (-102.2%)
0.24
est: 0.20 (+18.9%)
0.25
est: 0.22 (+14.7%)
0.27
est: 0.28 (-3.0%)
0.07
est: 0.28 (-76.5%)
0.69
est: 0.37 (+88.6%)
0.48
est: 0.51 (-6.5%)
0.19
est: 0.54 (-64.6%)
1.02
est: 0.98 (+4.6%)
1.31
est: 1.27 (+2.9%)
1.19
est: 1.35 (-12.2%)
1.39
est: 1.39 (+0.3%)
1.29
est: 1.34 (-3.8%)
1.41
est: 1.42 (-0.8%)
1.52
est: 1.57 (-3.4%)
1.85
est: 1.82 (+1.9%)
1.86
est: 1.96 (-5.0%)
1.73
est: 1.87 (-7.5%)
1.55
est: 1.70 (-9.0%)
2.30
est: 2.38 (-3.4%)
4.66
est: 2.63 (+76.9%)
1.22
est: 1.17 (+4.6%)
1.14
est: 1.36 (-16.3%)
0.44
est: 1.42 (-68.9%)
1.57
1.51 – 1.74
+10.9% YoY
1.77
1.69 – 1.96
+12.8% YoY
1.95
1.80 – 2.09
+9.9% YoY
2.18
2.11 – 2.31
+11.9% YoY
2.28
2.21 – 2.41
+4.7% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-29 B 3/5 4/5 3/5 4/5 2/5 1/5 3/5
2026-05-28 B 3/5 4/5 3/5 4/5 2/5 1/5 3/5
2026-05-27 B 3/5 4/5 3/5 4/5 2/5 1/5 3/5
2026-05-26 B 3/5 4/5 3/5 4/5 2/5 1/5 3/5
2026-05-22 B 3/5 4/5 3/5 4/5 2/5 1/5 3/5
2026-05-21 B 3/5 4/5 3/5 4/5 2/5 1/5 3/5
2026-05-20 B 3/5 4/5 3/5 4/5 2/5 1/5 3/5
2026-05-19 B 3/5 4/5 3/5 4/5 2/5 1/5 3/5
2026-05-18 B 3/5 4/5 3/5 4/5 2/5 1/5 3/5
2026-05-15 B 3/5 4/5 3/5 4/5 2/5 1/5 3/5
2026-05-14 B 3/5 4/5 3/5 4/5 2/5 1/5 3/5
2026-05-13 B 3/5 4/5 3/5 4/5 2/5 1/5 3/5
2026-05-12 B 3/5 4/5 3/5 4/5 2/5 1/5 3/5
2026-05-11 B 3/5 4/5 3/5 4/5 2/5 1/5 3/5
2026-05-08 B 3/5 4/5 3/5 4/5 2/5 1/5 3/5
2026-05-07 B 3/5 4/5 3/5 4/5 2/5 1/5 3/5
2026-05-06 B 3/5 4/5 3/5 4/5 2/5 1/5 3/5
2026-05-05 B 3/5 4/5 3/5 4/5 2/5 1/5 3/5
2026-05-01 B 3/5 4/5 3/5 4/5 1/5 1/5 3/5
2026-04-30 B 3/5 4/5 3/5 4/5 1/5 1/5 3/5
2026-04-29 B 3/5 4/5 3/5 5/5 1/5 1/5 3/5
2026-04-28 B 3/5 4/5 3/5 5/5 1/5 1/5 3/5
2026-04-27 B 3/5 4/5 3/5 5/5 1/5 1/5 3/5
2026-04-24 B 3/5 4/5 3/5 5/5 1/5 1/5 3/5
2026-04-23 B 3/5 4/5 3/5 5/5 1/5 1/5 3/5
2026-04-22 B 3/5 4/5 3/5 5/5 1/5 1/5 3/5
2026-04-21 B 3/5 4/5 3/5 5/5 1/5 1/5 3/5
2026-04-20 B 3/5 4/5 3/5 5/5 1/5 1/5 3/5
2026-04-17 B 3/5 4/5 3/5 5/5 1/5 1/5 3/5
2026-04-16 B 3/5 4/5 3/5 5/5 1/5 1/5 3/5
2026-04-15 B 3/5 4/5 3/5 5/5 1/5 1/5 3/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
36.66M
OE per share TTM
0.24
Owner's Yield
0.84%
Maintenance CapEx ratio
4,393.14%
Maint CapEx / Avg PPE
62.2%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
40.4K
Shares Outstanding
139.59M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Stephen Edward Foots Group Chief Executive & Executive Director 2M male
Stephen Richard Oxley Chief Financial Officer & Executive Director 918.7K male
Michelle Fargen Global Head of Procurement and Sustainable Sourcing — —
Michelle Lydon President of Human Resources — female
Philip Ruxton Chief Sustainability Officer — male
Sandra Elaine Breene President of Consumer Care — female
Stephen W. Burgess Managing Director of Nucleic Acid Delivery — —
Thiru Selvan President of Supply Chain Operations — male
Thomas Michael Brophy Group General Counsel, Company Secretary & President Sustainability — male
Anthony Damien Fitzpatrick President of Strategy, Corporate Development & Industrial Specialties — male
Thomas Riemeier President of Life Sciences — male
David Bishop Director of Investor Relations — male
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Chemicals - Specialty